Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

Apixaban, a new anticoagulant, appears to offer an efficacy and safety profile comparable with that of enoxaparin for preventing VTE after orthopedic surgery, with the advantage of oral ...

During a search of the vehicle, officers seized from under Wiegand's seat 74 tablets, or 36.45 grams, of ecstasy, according to the affidavits. In addition to the drug charge, Wiegand is charged ...

On top of that, there are some terrific cheap tablet deals available right now. You can also save on Apple’s iPad, the iPad Pro, and Android tablets with free shipping. Check out the best laptop ...

The OCEANIC-AF trial randomized patients to either the novel factor XIa inhibitor asundexian 50 mg once daily or apixaban 5 mg or 2.5 mg twice daily ... and 12,317 patients were OAC-experienced (mean ...

Ruxolitinib for treating acute graft versus host disease that responds inadequately to corticosteroids in people 12 years and over TA1054 15 April 2025 15 April 2025 ...